Welcome to LookChem.com Sign In|Join Free
  • or
1-Aminocyclopentane-1,2-dicarboxylic acid is an organic compound with the molecular formula C7H11NO4. It is a cyclic amine derivative, featuring a cyclopentane ring with two carboxylic acid groups at the 1 and 2 positions and an amino group at the 1 position. 1-aminocyclopentane-1,2-dicarboxylic acid is known for its potential applications in the synthesis of various pharmaceuticals and chemical intermediates, particularly in the development of drugs targeting the central nervous system. Its unique structure allows for the formation of complex molecules through chemical reactions, making it a valuable building block in organic chemistry.

7399-37-3

Post Buying Request

7399-37-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7399-37-3 Usage

Chemical Structure

Bicyclic amino acid derivative

Function

Agonist at the N-methyl-D-aspartate (NMDA) receptor

Type

Synthetic compound

Therapeutic Potential

Neurological and psychiatric disorders

Specific Disorders

Schizophrenia, Alzheimer's disease

Mechanism of Action

Modulates the activity of the NMDA receptor

Role of NMDA Receptor

Synaptic plasticity and cognition

Research Status

Pre-clinical and clinical studies

Potential Intervention

Pharmacological intervention for neurological and psychiatric conditions

Additional Properties

Neuroprotective and neurotrophic properties

Field of Interest

Neuropharmacology

Check Digit Verification of cas no

The CAS Registry Mumber 7399-37-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,9 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 7399-37:
(6*7)+(5*3)+(4*9)+(3*9)+(2*3)+(1*7)=133
133 % 10 = 3
So 7399-37-3 is a valid CAS Registry Number.

7399-37-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-aminocyclopentane-1,2-dicarboxylic acid

1.2 Other means of identification

Product number -
Other names CB 1701

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7399-37-3 SDS

7399-37-3Downstream Products

7399-37-3Relevant academic research and scientific papers

Identification of selective norbornane-type aspartate analogue inhibitors of the glutamate transporter 1 (GLT-1) from the chemical universe generated database (GDB)

Luethi, Erika,Nguyen, Kong T.,Bürzle, Marc,Blum, Lorenz C.,Suzuki, Yoshiro,Hediger, Matthias,Reymond, Jean-Louis

experimental part, p. 7236 - 7250 (2010/12/25)

A variety of conformationally constrained aspartate and glutamate analogues inhibit the glutamate transporter 1 (GLT-1, also known as EAAT2). To expand the search for such analogues, a virtual library of aliphatic aspartate and glutamate analogues was generated starting from the chemical universe database GDB-11, which contains 26.4 million possible molecules up to 11 atoms of C, N, O, F, resulting in 101026 aspartate analogues and 151285 glutamate analogues. Virtual screening was realized by high-throughput docking to the glutamate binding site of the glutamate transporter homologue from Pyrococcus horikoshii (PDB code: 1XFH) using Autodock. Norbornane-type aspartate analogues were selected from the top-scoring virtual hits and synthesized. Testing and optimization led to the identification of (1R*,2R*,3S*, 4R*,6R*)-2-amino-6-phenethyl-bicyclo[2.2.1]heptane-2,3-dicarboxylic acid as a new inhibitor of GLT-1 with IC50 = 1.4 μM against GLT-1 and no inhibition of the related transporter EAAC1. The systematic diversification of known ligands by enumeration with help of GDB followed by virtual screening, synthesis, and testing as exemplified here provides a general strategy for drug discovery.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7399-37-3